ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,800Medicare Part D Prescriptions Filled, Including Refills

Rank: 225 out of 676

$335K Total Retail Price of All Prescriptions

Rank: 323 out of 676

395 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 395 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 7,575 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
SIMVASTATIN 462 324 1 6
HYDROCHLOROTHIAZIDE 412 268 2 12
AMLODIPINE BESYLATE 316 276 3 3
LOVASTATIN 314 245 4 33
POTASSIUM CHLORIDE 305 210 5 9
BENAZEPRIL HCL 293 199 6 58
LISINOPRIL 267 210 7 5
OMEPRAZOLE 261 207 8 2
METFORMIN HCL 231 154 9 8
GLYBURIDE-METFORMIN HCL 196 117 R 10 76
AMLODIPINE BESYLATE-BENAZEPRIL 195 124 11 44
FUROSEMIDE 194 179 12 4
WARFARIN SODIUM 189 177 13 18
LEVOTHYROXINE SODIUM 186 156 14 7
METOPROLOL TARTRATE 155 113 15 22
DIGOXIN 146 129 16 52
ALENDRONATE SODIUM 145 124 17 61
MELOXICAM 123 76 18 13
DONEPEZIL HCL 110 110 19 24
ATORVASTATIN CALCIUM 108 81 20 20
NAPROXEN 100 76 21 71
CRESTOR 97 90 22 29
GABAPENTIN 95 83 23 10
NIASPAN 90 61 24 162
DILTIAZEM ER 87 72 25 118
METOPROLOL SUCCINATE 82 57 26 14
KLOR-CON M20 80 69 27 67
CITALOPRAM HBR 77 58 28 17
PRAVASTATIN SODIUM 77 74 28 11
CLONIDINE HCL 77 69 28 32
ALLOPURINOL 76 70 31 31
DOXYCYCLINE HYCLATE 75 55 32 82
TRIAMTERENE-HCTZ 75 56 32 43
NIZATIDINE 74 41 34 277
PHENYTOIN SODIUM EXTENDED 71 30 35 88
ATENOLOL 69 56 36 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 63 37 16
MEGESTROL ACETATE 67 54 R 38 111
EVISTA 64 64 39 119
TRAMADOL HCL-ACETAMINOPHEN 63 42 40 148
CEPHALEXIN 62 40 41 84
NAMENDA 62 62 41 35
CLOPIDOGREL 60 56 43 28
TRIAMTERENE-HYDROCHLOROTHIAZID 58 57 44 160
INDAPAMIDE 58 27 44 188
CARVEDILOL 57 50 46 15
DIOVAN 57 45 46 37
TAMSULOSIN HCL 55 53 48 38
LOSARTAN POTASSIUM 54 38 49 34
SYNTHROID 54 44 49 48
CIPROFLOXACIN HCL 53 34 51 45
ZETIA 52 52 52 89
TRAMADOL HCL 52 48 52 19
HYDRALAZINE HCL 50 36 54 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.